{"id":2615,"date":"2017-02-09T03:00:09","date_gmt":"2017-02-09T08:00:09","guid":{"rendered":"https:\/\/issels.com\/blog\/?p=2615"},"modified":"2017-01-21T16:16:13","modified_gmt":"2017-01-21T21:16:13","slug":"strategic-t-cells-use-may-be-the-key-to-effective-cancer-treatment","status":"publish","type":"post","link":"https:\/\/issels.com\/blog\/2017\/02\/09\/strategic-t-cells-use-may-be-the-key-to-effective-cancer-treatment\/","title":{"rendered":"Strategic T Cells Use May Be the Key to Effective Cancer Treatment"},"content":{"rendered":"<figure id=\"attachment_2245\" aria-describedby=\"caption-attachment-2245\" style=\"width: 200px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2245\" src=\"https:\/\/issels.com\/blog\/wp-content\/uploads\/2015\/12\/red-white-blood-cells.jpg\" alt=\"\" width=\"200\" height=\"259\" \/><figcaption id=\"caption-attachment-2245\" class=\"wp-caption-text\">Advanced T Cells<\/figcaption><\/figure>\n<p><span style=\"font-family: 'Arial',sans-serif;\">T cells are the warriors of your immune system, but the ongoing battle against cancer can sap them of their disease-fighting powers. New research has discovered crucial information about these &#8220;exhausted&#8221; cells that can lead to more powerful <\/span><a href=\"http:\/\/issels.com\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">immunotherapy for cancer<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\">.<\/span><\/p>\n<p><span style=\"font-family: 'Arial',sans-serif;\">The fundamental difference between <\/span><a href=\"http:\/\/news.harvard.edu\/gazette\/story\/2016\/10\/new-approach-to-cancer-treatment-carries-success-with-caveat\/\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">active and exhausted T cells<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\"> lies in their gene patterns. One example is PD-1, a protein expressed by exhausted T cells that prevents them from attacking both healthy and diseased cells. Checkpoint inhibitors can block PD-1, but their use is productive in only 25 percent of cases.<\/span><\/p>\n<p><strong><span style=\"font-family: 'Arial',sans-serif;\">Can &#8220;Exhausted&#8221; T Cells Be Revived?<\/span><\/strong><\/p>\n<p><span style=\"font-family: 'Arial',sans-serif;\">According to Nicholas Haining of Dana-Farber\/Boston Children&#8217;s, senior author of the report posted in the journal <em>Science<\/em>, the goal of the study was to determine whether exhausted T cells are simply run-down versions of functional T cells or a separate type entirely. Regulatory regions of T cell genomes were mapped using chronically infected mice as subjects.<\/span><\/p>\n<p><span style=\"font-family: 'Arial',sans-serif;\">Results showed that the two types of cells are controlled by completely different wiring. In a separate study, use of <\/span><a href=\"https:\/\/issels.com\/blog\/2016\/08\/18\/non-specific-cancer-immunotherapy-stimulates-the-immune-system\/\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">checkpoint inhibitors<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\"> gave the exhausted T cells a temporary boost, but did nothing to convert them to an active state.<\/span><\/p>\n<p><span style=\"font-family: 'Arial',sans-serif;\">The researchers hope this information will help to improve CAR T-cell therapy, in which <\/span><a href=\"https:\/\/issels.com\/blog\/2016\/04\/14\/new-treatment-uses-t-cells-to-fight-cancer-at-the-root\/\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">T cells<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\"> are removed from a patient and retrofitted to attack tumor cells. Complete mapping of regulatory regions will provide more precise targets for treatment.<\/span><\/p>\n<p><strong><span style=\"font-family: 'Arial',sans-serif;\">Immunotherapy for Cancer Focuses on Tumors and Their Causes<\/span><\/strong><\/p>\n<p><span style=\"font-family: 'Arial',sans-serif;\">At Issels\u00ae, our <\/span><a href=\"http:\/\/issels.com\/treatment-summary\/\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">integrative programs<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\"> are aimed at eliminating cancer cells and enhancing your body&#8217;s own natural defense mechanisms. <\/span><a href=\"http:\/\/66.135.32.155\/issels\/Questionnaire\/request-issels-info.aspx\" target=\"_blank\"><span style=\"font-family: 'Arial',sans-serif;\">Contact us today<\/span><\/a><span style=\"font-family: 'Arial',sans-serif;\"> for more information.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>T cells are the warriors of your immune system, but the ongoing battle against cancer can sap them of their disease-fighting powers. New research has discovered crucial information about these &#8220;exhausted&#8221; cells that can lead to more powerful immunotherapy for cancer. The fundamental difference between active and exhausted T cells lies in their gene patterns. &hellip; <a href=\"https:\/\/issels.com\/blog\/2017\/02\/09\/strategic-t-cells-use-may-be-the-key-to-effective-cancer-treatment\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Strategic T Cells Use May Be the Key to Effective Cancer Treatment<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202,203,216],"tags":[222,259,574],"class_list":["post-2615","post","type-post","status-publish","format-standard","hentry","category-alternative-cancer-treatment","category-cancer-research","category-immunotherapy","tag-advanced-cancer-research","tag-fighting-cancer","tag-t-cell-treatment"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/comments?post=2615"}],"version-history":[{"count":1,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2615\/revisions"}],"predecessor-version":[{"id":2616,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2615\/revisions\/2616"}],"wp:attachment":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/media?parent=2615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/categories?post=2615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/tags?post=2615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}